Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would recommend reduce the dose and only use Tru Niagen in the morning.
Sweetamine is 8 mg of glycine which is 1 of 20 amino acids found in the body. I believe there is also some Taurine and Stevia added for taste. Glycine’s role among other things as I understand it, is to reduce inflammation. Sweetamine . Com, click on testimonials and see all the stories. I can attest to the fact that it has reduced the gout in my big toe amongst other pain caused by inflammation.
Didnt mean to hijack the Cdxc board just trying to share natural supplements to those in need.
Tred
Thanks. Good to know. I have mixed feelings about it. What is Sweetamine.
I used Tru Niagen for 60 days hoping to see major benefits. I did see increased energy and nail,hair growth as well but utimately it messed with my sleep as in getting very little deep sleep. Also my friend who is older, 75, tried it for 6 months and found the same thing. After contacting them they just had me try suspending the supplement for a few days as a recommendation. Not a good fit for me unfortunately. My latest try is Sweetamine for inflammation, 16 days into it my joints feel about 80% better.
Tred
I used Tru Niagen for 60 days hoping to see major benefits. I did see increased energy and nail,hair growth as well but utimately it messed with my sleep as in getting very little deep sleep. Also my friend who is older, 75, tried it for 6 months and found the same thing. After contacting them they just had me try suspending the supplement for a few days as a recommendation. Not a good fit for me unfortunately. My latest try is Sweetamine for inflammation, 16 days into it my joints feel about 80% better.
Tred
Thanks. Appreciate the info.
Everybody responds differently based on their metabolic health; young people might not be NAD deficient most of the time or ever. I'm 56, and have experienced significant improvements to RLS, possible improvements to skin and IBS, and the routine hair-and-nail-growth improvements that many report. Also, my hair seems to be less gray, although it certainly still has some gray, so I'm not sure abou that.
Has it helped you in any way?
Do I use Tru Niagen? 600mg/day, and a little extra if I am jet-lagged or if I over-ate. I have purchased from amazon and reviewed it there, but now I only buy from ChromaDex's website, where I sign up for auto-renew to get the best price, then cancel auto-renew, and sign-up for auto-renew again to get the best price again.
http://www.tkqlhce.com/click-8816047-13276255
Thanks. Do you use it!
Yes, they changed the pricing in February
https://www.right-of-assembly.org/single-post/2019/02/13/New-Pricing-for-Niagen-on-Amazon
The single bottle (now 300mg) is running $47.30:
https://amzn.to/2EweMcQ
Although really $42.30 if you clip the $5 coupon.
I suspect this has shifted a lot of repeat business to ChromaDex's own eCommerce site, where $30/bottle is available.
Not the same bottle size I was getting for $34.95.
You mean Tru Niagen on amazon? Works for me: https://amzn.to/2M6BSx5
It seems that Chromadex is no longer available on Amazon. Any info, anyone?
It has been overlooked that Anthony Suave in his new study declares NRH to be a "potent pharma agent that is 2.5 to 10 times
more potent than NR in raising NAD+ levels".
CDXC obtained a GRANTED patent covering NRH on 1-22-19 that will further the possibility of a pharma partner/buyout.
Scroll way down on the patent link to see a table comparing the potency of NRH to NR.
Is NRH the ultimate game changer?
https://www.ncbi.nlm.nih.gov/pubmed/30948509
Here it is covered in the recently granted patent:
https://patents.google.com/patent/US10183036B2/en?q=NRH&assignee=Chromadex&oq=Chromadex+NRH
News: $CDXC ChromaDex Furthers TRU NIAGEN® Global Expansion in Canada with WELL Health Technologies
LOS ANGELES, April 24, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today a new distribution partnership for TRU NIAGEN® with Vancouver-based WELL Health Technologies Corp. (TSX.V: WELL) who intends on distributing TRU NIAGEN® via its partner network of pharmac...
In case you are interested https://marketwirenews.com/news-releases/chromadex-furthers-tru-niagen-xae-global-expansion-in-canada-with-well-health-technologies-8048174.html
As an example of the immense research going on into Nad+ precursors is Dr. Brunhilde Felding's work at Scripps Research in San Diego. They have discovered that by boosting Nad+ levels breast cancer metastasis can be halted:
https://www.scripps.edu/felding/images/FeldingLabStudiesHandout.pdf
https://www.scripps.edu/felding/research.html
Chromadex supplied the NR for this study and has licensed the pending parent from Scripps:
http://investors.chromadex.com/phoenix.zhtml?c=212121&p=irol-newsArticle&ID=2280200
for the scientists out there:
https://www.sciencedirect.com/science/article/pii/S0163725819300592
Who is paying for Elysium's unending hyper litigious behavior and what is their end game?
Is it that Dr. Photoshop and Dr. Resveratrol missed NR/NAD and they and their supporters have been doing everything they can to stall/hinder/obstruct CDXC until they can get back in the lead where they obviously believe they alone belong?
DE Court Sits on Stay Motion
The judge hearing ChromaDex's patent infringement action has been sitting on Elysium's stay motion for five months -- that is highly unusual.
https://www.right-of-assembly.org/single-post/2019/04/06/The-Endless-Stay-in-Delaware
Dr. Charles Brenner to speak at Sixth Annual Biohacking Conference April 5-7
https://www.usalifesciences.com/gate/v3/news_details.php?news_id=167357
ChromaDex Appeals PTAB Decision...
so the PTAB's decision with respect to all five claims in the '807 patent will be reviewed. Good.
https://www.right-of-assembly.org/single-post/2019/03/21/ChromaDex-Appeals-PTAB-Decision
Important new decision on the patentability of health supplements bodes well for ChromaDex:
https://www.right-of-assembly.org/single-post/2019/03/20/Another-Door-Slams-on-Elysium
Insider buying picking up after Jaksch cashes out
CDXC
http://www.openinsider.com/search?q=cdxc
************
The ChromaDex-Elysium litigation is surely teaching us about the limits of the legal system. As an attorney, this troubles me immensely, because our legal system is one of the things that makes civic life possible. But clearly the procedural protections are subject to gaming, and we have twice seen -- once in New York and currently in Delaware -- judges who simply refuse to rule on motions.
I'm glad you're confident. I own shares in a young biotech that went through one of those horrible "shareholder suits". It was the old routine, an amateurish attack piece on the internet followed by a junkyard securities lawyer using it as the basis to immediately (ie, an hour later) "solicit" shareholders to file a class action, and of course using a professional nuisance shareholder to do so. Their hack lawsuit failed, but not after the judge let them amend their transparently baseless complaint several times, us spending millions of dollars in defense, and them not getting punished or reprimanded for plainly abusing the courts.
Justice would be these unethical lawyers be disbarred. Or am I getting something wrong?
Not coincidentally, judges are lawyers too. Its the police policing themselves. This is why the courts are not viewed perhaps as the bastion of justice that it should be.
It's almost like piracy. The incentives and laws aren't really fit to deal with pirates (or abusive lawyers) properly, so the problems perpetuate. The pirates (in this case these scamming securities lawyers) can operate between those lines and get away with it. I'm glad we didn't just give in; we fought them off. We should have made that abusive lawyer jump the plank, too, but the system failed us.
The wheels of justice turn slowly, but they grind exceedingly fine.
Just saw an Elysium ad on TV the other day. It was very brief and stylistic. Smart move by them. Legal system is not much help for us so far, not sure why. Milarepa?
New Complaint in NY by ChromaDex
Very hard hitting
https://www.right-of-assembly.org/single-post/2019/03/08/ChromaDex-Proposes-Amended-Complaint-in-New-York
Elysium's Clawback Claim Denied.
https://www.right-of-assembly.org/single-post/2019/02/20/Elysiums-Clawback-Claim-Denied
Interesting developments in Discovery
https://www.right-of-assembly.org/single-post/2019/02/16/CDXC-Opposes-Clawback
An elementary place to keep up with the Frost-Honig-Brauser 'anticipation' of intrigue is Teri Buhl's blog:
http://www.teribuhl.com
just like the Trolls on our discussion board apparently anticipated, is pushing some intrigue around the Frost-Honig-Brauser connections.
I hope you're not referring to Investorshub's 'discussion board' as that would be a violation of their TOS. The Frost-Honig-Brauser connections could indeed prove problematic, not ongoing SEC investigations of the three necessarily, but the capability for mischievousness on the part of one of the three in particular.
I'm a stockholder and customer of Chromodex.
Discovery is heating up in California -- Here are Elysium's Subpoenas for third parties Phillip Frost and Iconiq:
https://www.right-of-assembly.org/single-post/2019/02/08/Elysium-Subpoenas-Frost-and-Iconiq
Scathing Denial of Elysium's Reconsideration Motion in NY
https://www.right-of-assembly.org/single-post/2019/02/07/NY-Court-Denies-Elysiums-Motion-for-Reconsideration
Elysium Loses Again: Motion to Dismiss Denied in California
https://www.right-of-assembly.org/single-post/2019/02/06/CA-Court-Denies-Elysiums-Motion-to-Dismiss
CDXC Subpoenas Elysium Investor General Catalyst
https://www.right-of-assembly.org/single-post/2019/02/02/ChromaDex-Subpoenas-General-Catalyst
ChromaDex Prepared to Proceed with Patent Infringement Action Against Elysium Health
http://investors.chromadex.com/phoenix.zhtml?c=212121&p=irol-newsArticle_print&ID=2384419
Interesting new rodent study (mice and rats):
"NR supplementation of new mothers increases lactation and nursing behaviors and stimulates maternal transmission of macronutrients, micronutrients, and BDNF into milk. Pups of NR-supplemented mothers are advantaged in glycemic control, size at weaning, and synaptic pruning. Adult offspring of mothers supplemented during nursing retain advantages in physical performance, anti-anxiety, spatial memory, delayed onset of behavioral immobility, and promotion of adult hippocampal neurogenesis. Thus, postgestational maternal micronutrition confers lasting advantages to offspring."
https://www.cell.com/cell-reports/fulltext/S2211-1247(19)30015-4#.XEdBqy-KXdU.twitter
Elysium Moves for Reconsideration in New York
https://www.right-of-assembly.org/single-post/2019/01/21/Elysium-Moves-for-Reconsideration-in-New-York
ChromaDex's Opposes Elysium's Motion to Dismiss the Fifth Amended Complaint
https://www.right-of-assembly.org/single-post/2019/01/20/CDXCs-Opposition-to-Elysiums-Motion-to-Dismiss-the-5AC
It's the opposite: Elysium is trying to avoid paying royalties or infringement damages after Elysium stopped licensing ChromaDex's patents and instead produced its own competing (and apparently infringing) version.
Late to the game here. Broadly, is E seeking royalties from Chromadex based on alleged patent infringement.
Split Decision at PTAB
https://www.right-of-assembly.org/single-post/2019/01/17/Split-Decision-at-PTAB
Nice job, .
O/S is 55.32m, tiny float of 34.7m, Finviz & Nasdaq agree the short interest is at 3,875,900s short and shortsqueeze.com & finviz have the short % float @ 10.71% & 11.38% respectfully
shares short figures from the last report on 12/31/2018 down 5%, so the rather larger percentage of the tribe of true nonbelievers appears to be slowly waning. We'll know more in a day or so as the new report is due out today.
With that share structure things could change in a hurry either way.
https://www.finviz.com/quote.ashx?t=cdxc
http://shortsqueeze.com/?symbol=cdxc&submit=Short+Quote™
https://www.nasdaq.com/symbol/cdxc/short-interest
ChromaDex: The Bear Case
https://www.right-of-assembly.org/single-post/2019/01/13/ChromaDex-The-Bear-Case
Probably nothing. The important litigation now is before the Patent Trial and Appeal Board (should be resolved this month), and in federal court in California (trial in July) and Delaware (just getting started). ChromaDex is asserting claims for patent infringement and trade secret theft that could result in significant damage awards. Elysium will be trying to invalidate or otherwise evade ChromaDex's patents, either of which could have a big impact depending on who wins.
The FDA matter is now gone, and the remaining false advertising and unfair business practices claims in New York seem relatively unimportant, but I might change my mind depending on what develops there.
In sum: If either side wins on the big claims, or if investors think that the litigation is going to go away entirely, that would be more likely to influence the share price.
Stay tuned for the PTAB determination later this month (if not delayed by the government closure). If Elysium loses there, again, too, then people might start to conclude that their claims are specious and the litigation is not likely to go their way.
For more info, visit:
https://www.right-of-assembly.org/litigation
What does that imply for Chromadex earnings/share price? Are there still plenty of other legal issues to solve? New guy here and haven't had chance to read everything
Followers
|
90
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
3106
|
Created
|
10/28/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |